Friday, July 31, 2026

NVIDIA’s Boom: How Stock Options Turned Employees into Millionaires!

Benzinga estimated that employees who joined Nvidia five years ago have become millionaires, thanks to the stock price soaring.

Wontek’s V-Laser Approved for Versatile Treatments in Vietnam: A Game-Changer for Aesthetic Clinics

Wontech secures medical device approval for its V-Laser in Vietnam, enhancing its product lineup and market presence in medical aesthetics.

First Taekwondo Flag in Space: What This Means for the Future of the Sport

The World Taekwondo flag has made history by being launched into space, marking a first for international sports federations.

Tag: cancer research

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

SK Telecom, SK Biopharmaceuticals Use AI to Identify Drug Candidates for Hard-to-Treat Cancer Targeted Therapies

SK Telecom and SK Biopharmaceuticals use AI to identify early-stage cancer therapy candidates, reducing drug discovery time by over 60%.

Yonsei Researchers Discover Experimental Compound That Targets Drug-Resistant Metastatic Cancer Cells

A research team at Yonsei University has discovered a substance to treat resistant metastatic cancer.

HLB to Spotlight Liver and Bile Duct Cancer Pipeline at ASCO 2026 With Standalone Global Booth

HLB will showcase liver cancer drug candidates at ASCO 2026, including promising combination therapies and precision medicine studies.

AACR 2026 Highlighted Shift Toward Patient-Centered Cancer Drug Development, Foundation Says

Cancer research is evolving towards patient-centered outcomes, integrating data and technology for better treatments, as noted at AACR 2026.

Solum Healthcare Announces AI-Based Urine Test for Cancer at AACR Annual Meeting 2026

Solum Healthcare presented AI-driven non-invasive cancer detection using urine samples at AACR 2026, attracting global interest and discussions.

How Dong-A ST’s SC5024 and ADC Innovations Could Change the Game Cancer Pipeline

Dong-A ST showcased its innovative cancer pipeline at AACR 2026, featuring promising preclinical findings and advanced therapeutic strategies.

How Hanmi’s Dual Inhibitor HM97662 is Revolutionizing Cancer Treatment: Key Insights from AACR 2026

Hanmi Pharmaceutical to present nine groundbreaking cancer research studies at AACR 2026, showcasing innovative therapies and AI-driven analytics.

How Samsung Medical Center is Revolutionizing Cancer Patient Care in Asia with EORTC Partnership

Samsung Medical Center's Cancer Hospital partners with EORTC to enhance cancer patients' quality of life through patient-reported outcomes.

Breakthrough Cancer Drug BAL0891: Key Findings to be Revealed at AACR 2026

SillaJen's cancer drug BAL0891 will be presented at the AACR 2026 conference, highlighting its effects on gastric and breast cancer models.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

How Tumor Microenvironment Stiffness Fuels Cancer Aggressiveness: Key Insights from Pusan National University

A study reveals that tumor microenvironment stiffness increases cancer aggressiveness and treatment resistance, highlighting its significance in treatment strategies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.